Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Different effects of clopidogrel and clarithromycin on the enantioselective pharmacokinetics of sibutramine and its active metabolites in healthy subjects

Shinde, DD and Kim, H and Choi, J and Pan, W and Bae, SK and Yeo, C and Shon, J and Kim, D and Shin, JG (2013) Different effects of clopidogrel and clarithromycin on the enantioselective pharmacokinetics of sibutramine and its active metabolites in healthy subjects. Journal of Clinical Pharmacology. pp. 550-558.

Abstract

In this study, we assessed the effects of clopidogrel and clarithromycin, known CYP2B6 and CYP3A inhibitors, respectively, on the enantioselective disposition of racemic sibutramine in conjunction with CYP2B6 polymorphisms in humans. Sibutramine showed enantioselective plasma profiles with consistently higher concentrations of R-enantiomers. Clopidogrel and clarithromycin significantly increased the sibutramine plasma concentration, but their effects differed between enantiomers; a 2.2-fold versus 4.1-fold increase in the AUC in S-enantiomer and 1.8-fold versus 2.0-fold for the Renantiomer, respectively. The AUCs of S- and R-desmethyl metabolites changed significantly during the clopidogrel phase (P < .001 and P < .001, respectively) but not during the clarithromycin phase (P = .099 and P = .090, respectively). Exposure to sibutramine was higher in subjects with the CYP2B6*6/*6 genotype, but no statistical difference was observed among the CYP2B6 genotypes. These results suggest that the enantioselective disposition of sibutramine and its active metabolites are influenced by the altered genetic and environmental factors of CYP2B6 and CYP3A activity in vivo. The Author(s) 2013

Item Type: Article
Additional Information: pubid: 69 nvp_institute: NIBR contributor_address: (Shinde, Kim, Choi, Pan, Bae, Yeo, Shon, Kim, Shin) Department of Pharmacology, Inje University, College of Medicine, #633-165 Gaegum-Dong, Jin-Gu, Busan 614-735, South Korea (Yeo, Shon, Shin) Department of Clinical Pharmacology, Inje University Busan, Paik Hospital, Busan, South Korea (Pan) China Novartis Institutes, BioMedical Research Co., Ltd, Shanghai, China
Date Deposited: 13 Oct 2015 13:13
Last Modified: 13 Oct 2015 13:13
URI: https://oak.novartis.com/id/eprint/21912

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.